Toboroz
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
NCT07701941· 1/2. fázis· Daiichi Sankyo· Forrás
Toboroz
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
NCT07258290· Teleflex· Forrás
Contact: BIOMAG-III Project Manager
Toboroz
Determining the Prevalence of Muir-Torre Syndrome in Patients With Lynch Syndrome
NCT07201012· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa MEGZARI
Még nem toboroz
Assessment and Evolution of Narrative Identity and Its Relationship to Subjective Multidimensional Well-being and Multidimensional Recovery in First Episode Psychosis
NCT07330843· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa Megzari
Toboroz
Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity
NCT07292480· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa Megzari
Toboroz
Study of Sleep Inertia in Major Depressive Disorder by the Psychomotor Vigilance Task
NCT06732284· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa Megzari
Toboroz
Study Aiming to Compare the Plasma Exposure of the Payload (Free-DXd) in Patients Treated by T-DXd for Locally Advanced or Metastatic Breast Cancer According to Their BMI.
NCT07195344· 4. fázis· Institut Claudius Regaud· Forrás
Contact: Frédéric FITENI, MD
Toboroz
Proof of Concept Study on BP1.4979 Effect on Essential Tremor
NCT07074002· 2. fázis· Bioprojet· Forrás
Contact: Study Medical Director
Toboroz
Safety of Mesentery-embedding Surgery in Patients With Ileocolic Crohn's Disease on Biotherapy
NCT06856044· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa MEGZARI
Toboroz
Determination of Lipocalin Type-prostaglandin (L-PGDS) in Blood, Urine, Vaginal Samples and Endometrial Ablation by Enzyme-linked Immunosorbent Assay
NCT06864494· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa Megzari
Toboroz
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
NCT06620835· 2. fázis· Groupe Francais De Pneumo-Cancerologie· Forrás
Contact: Sylvie VAN HULST
Toboroz
Study of Sleep Disorders in Prodromal and Definite Parkinsons Disease
NCT06582121· Assistance Publique - Hôpitaux de Paris· Forrás
Contact: Beatriz ABRIL, MD
Toboroz
Detection of Homologous Recombination Pathway Gene Mutations in Circulating Tumour DNA From BRCA-mutated Ovarian Cancer Patients Receiving First-line PARP Inhibitor Maintenance Therapy
NCT06588322· Institut Claudius Regaud· Forrás
Contact: Frédéric FITENI
Toboroz
Association Between the SPHERTEST in Vitro Test and Response to Checkpoint Inhibitor Treatments in Patients With Advanced or Metastatic Urothelial Carcinoma
NCT06738797· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa MEGZARI
Fut, nem toboroz
Reduction in the Number of Chemotherapy Cycles in Combination With Pembrolizumab in First-line Treatment of PD-L1-positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinomas
NCT06557889· 2. fázis· Institut Claudius Regaud· Forrás
Toboroz
Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer
NCT06147960· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa MEGZARI
Toboroz
Safety & Efficacy of Ischemic Preconditioning by Embolization of the Inferior Mesenteric Artery in Surgery for Tumors of Lower and Middle Rectum
NCT06236633· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Martin BERTRAND, Pr
Toboroz
CARE1 Pragmatic Clinical Trial
NCT06364631· 3. fázis· Gustave Roussy, Cancer Campus, Grand Paris· Forrás
Contact: Nadine HOUEDE, MD, PhD
Toboroz
Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer
NCT06027632· Centre Francois Baclesse· Forrás
Contact: Frederic FITENI, MD
Fut, nem toboroz
Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France
NCT05924217· Centre Hospitalier Universitaire de Nīmes· Forrás
Toboroz
Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis
NCT06083584· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa Megzari
Toboroz
Study of Sagittal Pelvic Statics in the Sitting Position in Children With Cerebral Palsy
NCT05657548· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Mélanie PORTE
Toboroz
Optimization of the Surgical Care Pathway for Kidney Tumors by Digitizing Perioperative Nursing Coordination (UroCCR 126)
NCT06047600· University Hospital, Bordeaux· Forrás
Contact: Alexis Fontenil, Dr
Toboroz
Impact of a Multidisciplinary Approach in the Perioperative Geriatrics Unit on Functional Status of Patients Aged 70 and Over Operated on for Colorectal Cancer
NCT05993923· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Coralie LABARIAS
Toboroz
Rescue of Nephrons With ALE.F02 (RENAL-F02)
NCT06047171· 2. fázis· Alentis Therapeutics AG· Forrás
Contact: Mohamed Benabed
Toboroz
Impact of an Early Identification Program for First-Episode Psychosis on the Duration of Untreated Psychosis
NCT05813457· Centre Hospitalier Universitaire de Saint Etienne· Forrás
Contact: Aurélie SCHANDRIN, MD (principal investigator)
Fut, nem toboroz
Anticoagulation Therapy in Non-device-related Intra-cardiac Thrombus
NCT05825573· 3. fázis· Centre Hospitalier Universitaire de Nīmes· Forrás
Fut, nem toboroz
Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST)
NCT05454150· University Hospital, Lille· Forrás
Fut, nem toboroz
OFSEP Very High Definition Cohort
NCT05622643· EDMUS Foundation· Forrás
Toboroz
Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.
NCT05378204· Institut Claudius Regaud· Forrás
Contact: Frédéric FITENI
Fut, nem toboroz
Research of Circulating Tumor Cells Released During Cervical Cancer Surgery
NCT04770090· University Hospital, Montpellier· Forrás
Toboroz
Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma
NCT04749108· 2/3. fázis· Institut du Cancer de Montpellier - Val d'Aurelle· Forrás
Contact: Martin Bertrand, MD (principal investigator)
Fut, nem toboroz
Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type
NCT04285476· Institut du Cancer de Montpellier - Val d'Aurelle· Forrás
Fut, nem toboroz
The SELUTION DeNovo Study
NCT04859985· M.A. Med Alliance S.A.· Forrás
Toboroz
Situation and Evolution of the Misuse of Alcohol and Other Addictive Behaviors in Obese Patients Being Managed at Nîmes University Hospital
NCT04613791· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Anissa Megzari
Fut, nem toboroz
Descriptive Study of Variations in Serum Translocation Markers of the Intestinal Microbiota in Patients With Gougerot-Sjögren Syndrome According to Disease Activity
NCT04462601· Centre Hospitalier Universitaire de Nīmes· Forrás
Toboroz
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
NCT04585750· 1/2. fázis· PMV Pharmaceuticals, Inc· Forrás
Contact: Frédéric Fiteni, MD, PhD
Toboroz
Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency
NCT06827353· Centre Hospitalier Universitaire de Nīmes· Forrás
Contact: Sarah Kabani
Toboroz
French Colorectal ESD Cohort in Experts Centers
NCT04592003· University Hospital, Limoges· Forrás
Contact: Ludovic LC CAILLO, Dr
Toboroz
Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NCT03728049· University Hospital, Lille· Forrás
Contact: Eric Van Belle, MD,PhD
Fut, nem toboroz
Discriminant Capacity and Thresholds of Salivary Cortisol in Chemiluminescence in the Diagnosis of Hypercorticisms
NCT03974789· Centre Hospitalier Universitaire de Nīmes· Forrás
Fut, nem toboroz
Assessment of NfL and GFAP Levels, Atrophy of the Macula GCC by OCT and Whole Brain Atrophy by MRI to Predict Evolution of Neurological Disability in MS Patients
NCT04860947· Centre Hospitalier Universitaire de Nīmes· Forrás
Fut, nem toboroz
Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis
NCT03981003· Centre Hospitalier Universitaire de Nīmes· Forrás
Fut, nem toboroz
IDH2 (AG 221) Inhibitor in Patients With IDH2 Mutated Myelodysplastic Syndrome
NCT03744390· 2. fázis· Groupe Francophone des Myelodysplasies· Forrás
Fut, nem toboroz
OFSEP High Definition Cohort
NCT03603457· EDMUS Foundation· Forrás
Fut, nem toboroz
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
NCT03774732· 3. fázis· UNICANCER· Forrás
Toboroz
UroCCR Database: French Research Network for Kidney Cancer -UroCCR
NCT03293563· University Hospital, Bordeaux· Forrás
Contact: Alexis FONTENIL, Dr